Abstract

THREE ARM CLINICAL PILOT STUDY TO EVALUATE THE EFFICACY OF SIDHARTHAK RASKRIYA TOPICALLY, SIDHARTHAK KASHAYA ORALLY, AND BOTH COMBINED TOGETHER IN EKAKUSTHA WITH SPECIAL REFERENCE TO PSORIASIS

Dr. Abhijeet Sureshrao Bhendekar*, Dr. Eknath G. Kulkarni, Dr. Sanjivani N.
Rathod and Dr. Abhay Kulkarni

ABSTRACT

Introduction: In today's fast-paced world, many individuals arefocused on achieving their life goals, often at the expense of theirhealth. The adoption of sedentary lifestyles, artificial habits, and theneglect of proper daily routines (Dincharya), seasonal regimens(Rutucharya), and dietary guidelines has led to a rise in variousdermatological diseases. In Ayurveda, almost all skin diseases arecategorized under Kustha Rogadhikara and classified into MahaKustha and Kshudra Kustha. According to ancient Ayurvedic texts, alltypes of Kustha involve an imbalance of the three doshas Vata, Pitta,and Kapha—but the specific type of Kustha depends on thepredominance of a particular dosha. Eka-Kustha, though classified as aRakta Pradoshaja and primarily a Vata-Kapha dominant tridoshajaKshudra Kustha, closely resembles psoriasis in modern medical terminology. Psoriasis is a chronic, autoimmune, inflammatory skin disorder that isnotoriously difficult to cure. While modern medicine and other therapeutic approachesprovide relief, they often come with limitations and side effects, especially when used forextended periods. Psoriasis is a relapsing and remitting condition that can cause significantsocial isolation, cosmetic concerns, psychological distress, and challenges in maintaining anormal social life. Given these challenges, there is a growing need for more comprehensive,cost-effective, and safe treatments for managing psoriasis. Objective: To evaluate the role ofSidharthak Kashaya (taken orally) and Sidharthak Raskriya (used topically) in themanagement of Eka-Kustha (psoriasis). Methodology: This case series includes 15 patientssuffering from chronic Eka-Kustha. The patients were treated with Sidharthak Kashayaadministered orally and Sidharthak Raskriya applied topically. The treatment duration was 90days, during which the patients' symptoms, including itching and erythematous scaly patches,were assessed using the Psoriasis Area and Severity Index (PASI) both before and aftertherapy. Results: After the 90-day treatment period, significant relief in symptoms wasobserved. The patients showed considerable improvement in itching, scaling, and erythema,as indicated by their PASI scores. Overall, the treatment was effective, and satisfactoryresults were achieved.

Keywords: .